Health Canada
- Status: approved
🇨🇦 Ibrutinib 420 mg in Canada
Ibrutinib 420 mg (Ibrutinib 420 mg) regulatory status in Canada.
Marketing authorisation
Ibrutinib 420 mg in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Ibrutinib 420 mg approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Ibrutinib 420 mg in Canada?
Gruppo Italiano Malattie EMatologiche dell'Adulto is the originator. The local marketing authorisation holder may differ — check the official source linked above.